Seminars in Interventional Radiology · 2010 · 40 citations · 31 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyHemostasisInterventional CardiologyAnticoagulant TherapyAntiplatelet TherapyAntithrombotic TherapyPlatelet AggregationThrombosisThrombosis PreventionAntiplatelet DrugsAntiplatelet Therapy After Percutaneous Coronary InterventionGlycoprotein Iib FunctionGlycoprotein Iiia FunctionPlatelet Aggregation InhibitionPlatelet HemostasisPlatelet InhibitionPlatelet Thrombus Formation
The glycoprotein IIb/IIIa (GP IIb/IIIa) antagonists are the most recent additions to the antiplatelet agents available to the interventional radiologist. The currently available GP IIb/IIIa antagonists are abciximab, eptifibatide, and tirofiban. These medications have demonstrated excellent safety and efficacy in the setting of coronary arterial interventions. The fundamental benefit of the GP IIb/IIIa antagonists lies in their unique mechanism of action: the ability to prevent platelet aggregation, thrombus formation, and distal thromboembolism while preserving initial platelet binding to damaged vascular surfaces. A paucity of data exists regarding the role of GP IIb/IIIa inhibitors in peripheral vascular interventions. The GP IIb/IIIa antagonists would theoretically provide excellent antiplatelet therapy in patients undergoing any of a variety of endovascular interventions during which thrombosis or thromboembolism may endanger distal perfusion in patients with peripheral vascular disease. The goal of this summary is to review the indications for use, pharmacology, and evidence for efficacy of the GP IIb/IIIa antagonists in hopes of translating these data for application in the peripheral arterial circulation. Further research is necessary to determine how these agents may be safely used in combination with other anticoagulants or with stents, efficacy compared with standard regimens, success at preventing distal thromboembolism, and cost effectiveness.
31
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Sidney C. Smith, Ted Feldman, John W. Hirshfeld et al. · Circulation · 2006 · 2.2K citations
Medicine, Cardiology, Surgery +13
Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
Stephen G. Ellis, Michał Tendera, Mark de Belder et al. · New England Journal of Medicine · 2008 · 696 citations · Full text